GLB.L

Glanbia Plc
Glanbia PLC - Transaction in Own Shares
13th November 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9781L
Glanbia PLC
13 November 2024
 






Glanbia plc Transaction in Own Shares

 

 

 






Wednesday, November 13, 2024  Glanbia plc ("Glanbia" or the "Company"), the Better Nutrition company, announces that on  Tuesday, November 12, 2024  it purchased the following number of its ordinary shares (the "Ordinary Shares") on Euronext Dublin, via Glanbia's broker J&E Davy. The Ordinary Shares purchased will be cancelled.




Euronext Dublin


Number of Ordinary Shares purchased: 

40,000


Highest price paid per Ordinary Share:

€14.6200


Lowest price paid per Ordinary Share:

€14.4400


Volume weighted average price paid per Ordinary Share:

€14.5050








The Ordinary Shares purchased form part of Glanbia's intention to buy back the Company's Ordinary Shares of a total value of up to €50 million in the period up to 19 December 2024 ("Buy-Back Programme"). This Buy-Back Programme was announced on 14 August 2024 and formally commenced on that date.








Following settlement of the above transactions and subsequent share cancellation Glanbia will hold  259,573,959  ordinary shares in issue.








In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a detailed breakdown of individual trades made by Davy on behalf of Glanbia as part of the buyback programme is scheduled to this announcement.








Contact:






Liam Hennigan

Group Secretary and Head of Investor Relations

Tel: + 353 86 046 8375

 

Olivia Kennington






Deputy Group Secretary





Tel: + 35356 777 2200

 

 






 

Issuer name:


Glanbia plc


 

 

LEI


635400SRMCBHVMSKJS84


 

ISIN:


IE0000669501


 

Intermediary name:

J&E Davy


 

Intermediary code:

DAVYIE21



 

Time zone:


GMT



 

Currency:


EUR


 

 

 

 

 

 

 

Aggregated Information

 

 

 



 

 

 

 

 

 

 


 

Trading venue

Currency

Volume Weighted Average Price

Aggregated volume

 

Euronext Dublin

EUR

14.5050

40,000

 






 

Euronext Dublin

 

 






 

Number of
Shares

Price per Share (EUR)

Trading Venue

Time of Transaction

MatchId

10000

14.44

Euronext Dublin

 10:07:39

00043376158TRLO0-1

10000

14.62

Euronext Dublin

 12:42:56

00043377618TRLO0-1

10000

14.51

Euronext Dublin

 15:17:40

00043380002TRLO0-1

10000

14.45

Euronext Dublin

 15:27:12

00043380298TRLO0-1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBCBDBUGBDGSD]]>
TwitterFacebookLinkedIn